11:35am - 12:15pm Monday, March 9

Location & Room

Orlando - Hyatt Regency
Hyatt - Orlando Ballroom L
Extra Fee

Pharma companies attend HIMSS for various reasons, but many walk the show floor searching for innovative start-ups with solutions capable of delivering better outcomes and a competitive advantage in the marketplace.

In this session, Naomi Fried, a respected industry thought leader, joins with Eli Lilly and Company’s Director, Digital Health Innovation James Parshall to explore what pharma companies look for in an innovative start-up with potentially disruptive technology.

Key discussion points include:

  • What did Lilly learn last year from its first open Innovation Challenge?

  • What are good expectations for pharma and start-ups to have for each other?

  • What might a successful collaboration look like?

This session will get to the heart of what success looks like for all: patients, pharma, and start-up.

Director, Digital Health External Innovation,
Eli Lilly and Company
Chief Executive Officer,
Health Innovation Strategies
Principal Investigator, Digital Health Research Lab,
Klick Health